At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy and Safety of Latanoprost (Xalatan) and Bimatoprost (Lumigan) Ophthalmic Solutions in Promoting Eyelash Growth in Patients With Alopecia Areata
In Brief
A clinical study evaluating Latanoprost (Xalatan), Bimatoprost (Lumigan), and 1 other intervention for Alopecia Areata. Completed, enrolled 14 participants across 1 site.
Detailed Summary
This is a single center, randomized, investigator-masked study to determine the efficacy and safety of latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients who have lost their eyelashes due to alopecia areata. These medications are FDA-approved as eyedrops for patients with glaucoma who have been noted to grow longer, darker, and thicker eyelashes with their use. In this study, patients will be asked to apply these solutions to the affected eyelid margins of one eye with a sterile cotton-tipped applicator once a day.
Study Details
Timeline
Interventions
Bimatoprost solution will be applied to affected eyelid(s) with cotton-tipped applicator daily.
Subject will apply latanoprost to affected eyelid with cotton-tipped applicator daily.